Literature DB >> 20528150

Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China.

Lin Li1, Lili Chen, Shaomin Yang, Yongjian Liu, Hanping Li, Zuoyi Bao, Zheng Wang, Daomin Zhuang, Siyang Liu, Jingyun Li.   

Abstract

Recombination contributes substantially to the genetic diversity of HIV-1, and mosaic strains arise frequently, especially in populations in which multiple subtypes circulate. Yunnan, which borders the "Golden triangle" region of Southeast Asia in the south, was considered as the epicenter of China. B, CRF01_AE, CRF07_BC, and CRF08_BC are all currently involved in the HIV-1 epidemiology in the area, which suggested the possible emergence of a new recombination. This study presented a near full-length genomic analysis of a novel HIV-1 recombination involving B and C. Different from the reported CRF07_BC and CRF08_BC, the new recombination revealed more breakpoints. This is the first report of a novel recombination involving subtype B and C in Yunnan, China. More work is needed to determine the epidemiologic significance of the new recombination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528150     DOI: 10.1089/aid.2010.0001

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Identification of a novel HIV Type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_AE and subtypes B and C in Western Yunnan, China.

Authors:  Yi Feng; Huamian Wei; Jenny Hsi; Hui Xing; Xiang He; Lingjie Liao; Yanling Ma; Chuanyi Ning; Nidan Wang; Yutaka Takebe; Yiming Shao
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01-04       Impact factor: 2.205

2.  Construction of Machine Learning Models to Predict Changes in Immune Function Using Clinical Monitoring Indices in HIV/AIDS Patients After 9.9-Years of Antiretroviral Therapy in Yunnan, China.

Authors:  Bingxiang Li; Mingyu Li; Yu Song; Xiaoning Lu; Dajin Liu; Chenglu He; Ruixian Zhang; Xinrui Wan; Renning Zhang; Ming Sun; Yi-Qun Kuang; Ya Li
Journal:  Front Cell Infect Microbiol       Date:  2022-05-12       Impact factor: 6.073

3.  Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC.

Authors:  Qiwei Zhang; Xiaomin Zhang; Hao Wu; Donald Seto; Hao-Jie Zhang; Zhiwei Chen; Chengsong Wan; Bo-Jian Zheng
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

4.  Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.

Authors:  Rui-Rui Wang; Qing-Hua Yang; Rong-Hua Luo; You-Mei Peng; Shao-Xing Dai; Xing-Jie Zhang; Huan Chen; Xue-Qing Cui; Ya-Juan Liu; Jing-Fei Huang; Jun-Biao Chang; Yong-Tang Zheng
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

5.  AIDS prevention and control in the Yunnan region by T cell subset assessment.

Authors:  Ya Li; Chenglu He; Zengpin He; Min Zhong; Dajin Liu; Ruiyang Liu; Ruixuan Fan; Yong Duan
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

6.  DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOs.

Authors:  Xing-Jie Zhang; Li-He Lu; Rui-Rui Wang; Yue-Ping Wang; Rong-Hua Luo; Christopher Cong Lai; Liu-Meng Yang; Yan-Ping He; Yong-Tang Zheng
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.